Porphyria was induced in C57BL/10 mice with iron overload by a single oral dose (100 mg/kg) of hexachlorobenzene (HCB). Within 2 weeks hepatic uroporphyrinogen decarboxylase (EC 4.1.1.37) was inhibited, reaching a maximum (> 95%) at 6-8 weeks. There was no recovery by 14 weeks, despite a fall in liver HCB concentrations to only 6% of the day-3 value. The major rise in hepatic porphyrin levels occurred after 4 weeks and secondary inhibition of uroporphyrinogen synthase (EC 4.2.1.75) was inferred from the progressively greater proportion of uroporphyrin I present relative to the III isomer. Plasma alanine aminotransferase (EC 2.6.1.2) activity was also elevated. Although, in further studies, total microsomal cytochrome P-450 content and ethoxyphenoxazone de-ethylase activity reached a peak a few days after dosing and had declined significantly at the time of maximum inhibition of the decarboxylase, additional treatment of HCB-dosed mice with a cytochrome P1-450 inducer, ,i-naphthoflavone, enhanced the inhibition, whereas piperonyl butoxide, an inhibitor ofcytochrome P-450, partially protected. Uroporphyrinogen decarboxylase was not radiolabelled in vivo by [14C]HCB. There was no major difference in the ability to hydroxylate HCB between hepatic microsomes from induced C57BL/10 mice and those from the insensitive DBA/2 strain. By contrast, lipid peroxidation, in the presence of NADPH, was 8-fold greater in control C57BL/10 microsomes than in DBA/2 microsomes and was stimulated by iron treatment (although not by HCB). The results suggest that the inhibition of hepatic uroporphyrinogen decarboxylase is unlikely to be due to a direct effect of a metabolite of HCB but to another process requiring a specific cytochrome P450 isoenzyme and an unknown iron species.
INTRODUCTION
Porphyria cutanea tarda (PCT) is a human disease characterized by an abnormality of haem biosynthesis in which uroporphyrinogen--decarboxylase '(EC 4.1.1.37) activity is depressed . There are at least two classes of the disease. In the first there is a family history of the condition, familial PCT, and enzyme activity is low in all tissues that have been exanmined . The types of PCT in this class arise by expressions ofmutations of the decarboxylase gene (Elder et al., 1985; Sassa et al., 1983; de Verneuil et al., 1984) . In the second Qlass, referred to as sporadic or acquired PCT, the depression of decarboxylase activity is restricted to the liver (Elder et al., 1985; Kappas et al., 1983) . It is the most common of all forms of porphyria and occurs mainly in patients with high or moderately-high intakes of alcohol and who have no family history of PCT . The mechanism of the enzyme defect in sporadic PCT is unknown but remission can be achieved by lowering hepatic iron stores Elder et al., 1985) . A similar disease has occurred in people poisoned by hexachlorobenzene (HCB) and related chemicals (Elder, 1978; Smith & De Matteis, 1980; Kappas et al., 1983) . Even with sporadic and HCB-induced PCT there may be a genetic predisposition to the disease as alcohol-induced liver damage or exposure to HCB does not necessarily cause the development of porphyria in the majority of individuals (Dogramaci, 1964; Smith & De Matteis, 1980; Kappas et al., 1983) .
Rats, like humans, become porphyric by depression of uroporphyrinogen decarboxylase activity when they are fed HCB continuously (Ockner & Schmid, 1961; De Matteis et al., 1961; Elder, 1978) and there is evidence for potentiation by iron (Taljaard et al., 1972; Louw et al., 1977; Smith et al., 1979) . This has been studied by many workers as a model for human PCT. Mice exposed to HCB appeared to be too susceptible to neurotoxic effects to be a model for PCT (De Matteis et al., 1961) but they can become highly sensitized to the porphyrogenic actions of HCB after iron overload (Smith & Francis, 1983) perhaps via a free radical-induced or related process (De Matteis & Stonard, 1977; Jones et al., 1981) . What is more, this susceptibility is genetically determined and seems to be associated with, but not wholly dependent on, the responsiveness of the mice to the induction of certain microsomal enzymes by some drugs and environmental chemicals (Eisen et al., 1983; Smith & Francis, 1983; Smith et al., 1986a ). Here we report that porphyria can be induced in susceptible inbred mice preloaded with iron by a single exposure to HCB. This protocol has allowed us to follow the sequence of enzymic and other changes that occur leading to overt porphyria and to examine possible mechanisms of enzyme inhibition.
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A preliminary account of these data was presented at the conference on Porphyrins and Porphyrias, Paris, 1985. (Jackson et al., 1976 ) and found to be > 90% the disomer by n.m.r. (Professor A. H. Jackson, personal communication) . Ethoxyphenoxazone was synthesized as described elsewhere (Smith et al., 1986a) .
EXPERIMENTAL
Mice and protocols Male C57BL/lOScSn and DBA/2Nimr mice (7-10 weeks old) were bred in these laboratories and fed Breeder Diet no. 3 expanded (Special Diet Services,-Witham, Essex, U.K.). Iron as Imferon was given by subcutaneous injection (10ml/kg) 3 days before the beginning of an experiment. HCB was dissolved in warm corn oil (10 mg/ml) and given to mice by oral intubation (100 mg/kg; 0.35 mmol/kg). Phenobarbital (60 mg/kg), ,8-naphthoflavone (100 mg/kg), isosafrole (100 mg/kg), piperonyl butoxide (100 mg/kg) and butylated hydroxyanisole (150 mg/kg) were given by intraperitoneal injection dissolved in physiological saline or corn oil (4 ml/kg) as appropriate and when indicated. Animals that received HCB were kept in a negative pressure isolator. Mice were killed either with CO2 or by cervical dislocation. In experiments involving the assay of uroporphyrinogen decarboxylase, livers were frozen in liquid N2 and stored at -70°C until analysed.
Microsomal fractions were prepared from fresh tissue.
Analyses
Plasma alanine aminotransferase (EC 2.6.1.2) was assayed on blood obtained by heart puncture using a kit (No. 57-UV) purchased from Sigma (Greig et al., 1984) .
Livers were homogenized in 0.25 M-sucrose (1:4, w/v). Porphyrin concentrations were estimated by fluorescence spectroscopy and are expressed in terms of uroporphyrin (Granick et al., 1975; Smith et al., 1979) . Proportions of uroporphyrin and heptacarboxyporphyrin and analysis of uroporphyrin isomers I and III were determined by h.p.l.c. (Smith & Francis, 1983; . HCB levels were estimated by g.l.c. (Rizzardini & Smith, 1982; Smith & Francis, 1983) . Non-haem iron concentrations in livers were determined by a modified method of Torrance & Bothwell (1968) .
To assay uroporphyrinogen decarboxylase activity, homogenate was centrifuged at 40000 g for 30 min and the supernatant incubated with pentacarboxyporphyrinogen L (5 sM) in 0.1 mM-EDTA/3 mm-dithiothreitol/ 50 mM-sodium succinate buffer (pH 5.4) under N2 in the dark at 37°C for 10 min . Incubations were then acidified to 0.5 M-HCI, centrifuged at 1000 g for 5 min, and the coproporphyrinogen I formed per mg of protein was quantified (as the porphyrin analogue) by reversed-phase h.p.l.c. . For a given enzyme source and batch of pentacarboxyporphyrin I the reproducibility of the assay showed < 5% variation.
Microsomes were prepared from homogenate in two ways. In the time study of cytochrome P450 induction, microsomal fractions were prepared by single centrifugation at 100000g of the post-mitochondrial fraction (Smith et al., 1986a) and used immediately. Cytochrome P-450 content was estimated by the method of Omura & Sato (1964) and ethoxyphenoxazone de-ethylase as in Smith et al. (1986a) . Cytosolic NAD(P)H quinone reductase [diaphorase (EC 1.6.99.2)] was assayed with 2,6-dichloroindophenol and NADH as substrates (Smith et al., 1986a) . For other studies washed microsomes were prepared essentially as described in Stewart & Smith (1986) and stored in a glycerol/0.1 M-Na2HPO4/ NaH2PO4 buffer, pH 7.4 (1:4, v/v) at -70°C until used.
Proteins in supernatants and microsomal fractions were estimated with bovine serum albumin (Sigma) as a standard essentially by the method of Lowry et al. (1951) (Stewart & Smith, 1986) .
All results are means + S.E.M. and significance was assessed by Student's 1-test.
Microsomal metabolism of HCB and peroxidation studies
Incubations with HCB-induced microsomes were based on those described for rats (Stewart & Smith, 1986) and consisted of 3.4 ml of 0.1 M-Na2HPO4/NaH2PO4 buffer (pH 7.4), 13 mg of microsomal protein and 100 nmol of HCB added in 30 ,d of acetone. Following a 4 min preincubation period at 37°C, incubations were initiated with an NADPH-regenerating system. After 30 min some reactions were terminated by extraction with ethyl acetate and the metabolism of HCB estimated by the formation of pentachlorophenol (Stewart & Smith, 1986) . The limit of detection was 0.05 pmol/min per mg of microsomal protein. Other incubations were placed in ice and malondialdehyde formed by peroxidation oflipid was estimated with thiobarbituric acid (Slater & Sawyer, 1971) . Similar incubations at 20°C were used to measure NADPH oxidation at 340 nm and 02 consumption in control microsomes.
Incubations of cytosol with control or HCB-induced C57BL/ 10 microsomes (5 days) were conducted as above for 20 min except that 1.5 ml of the 0.1 M-Na2HPO4/ NaH2PO4 buffer was substituted with 1.5 ml of control 100000 g cytosol. Decarboxylase activity in a portion of the mixtures was then estimated as above.
Partial purification of uroporphynnogen decarboxylase after [14CJHCB Liver from C57BL/10 mice with iron overload that had received [14C]HCB (see the Results section) was homogenized in 0.25 M-sucrose (1:4, w/v), gently mixed with cellulose phosphate P11 ion exchanger (1: 10, w/v) and centrifuged at 40000 g for 30 min at 4 'C. The supernatant was applied to a 20 cm x 3 cm DEAE-Sephacel column (Pharmacia) and eluted with 2-3 column vol. each of 10, 50 and porphyrin levels, (c) hepatic HCB concentrations, and (d) plasma alanine aminotransferase activity Mice predosed with Imferon (10 ml/kg 3 days previously) received HCB (100 mg/kg; 0.35 mmol/kg) and were killed at intervals. Hepatic and plasma parameters were determined as described in the Experimental section. Results are means+S.E.M. for four mice per group. Decarboxylase activities were measured in four groups consisting of one liver from each time point. At 2 weeks enzyme activities were significantly different from zero time values (P < 0.01), as were every subsequent time. Porphyrin levels were not significantly different from zero time until 5 weeks (P < 0.01). 100 mM-Na2HPO4/NaH2PO4 buffers (pH 6.8). The fractions eluted by the last buffer that contained decarboxylase activity were precipitated with (NH4)2SO4 (75% satd.) and then applied in 100 mM-phosphate buffer to a 15 cm x 2 cm phenyl-Sepharose (Pharmacia) column equilibrated with 0.8 M-(NH4)2SO4. After elution with this (NH4)2SO4 solution followed by 2mM-Na2PO4/ NaH2PO4 buffer (pH 6.8) (Smith & Francis, 1983) . Further studies showed that hepatic porphyria in C57BL/10 mice with iron overload could be induced by a single oral dose of HCB (100 mg/kg; 0.35 mmol/kg) (Fig. 1) (Fig. 1 c) . A logarithmic plot of the data illustrated that the decline consisted of two phases with half-lives of about 3 and 6 weeks. At 14 weeks HCB levels were only 6% of the values at 3 days and thus did not correlate with decarboxylase inhibition.
Plasma levels of alanine aminotransferase were also determined as an estimate of liver damage during the course of the experiment (Fig. ld) (0) were determined by h.p.l.c. of 40000 g supernatant as described previously (Smith & Francis, 1983; .
enzyme was assayed in the presence of added porphyrins. Uroporphyrins I and III and heptacarboxyporphyrin III inhibited the decarboxylation ofpentacarboxyporphyrinogen I to coproporphyrinogen I; however, this only accounted for 3% of the inhibition of the enzyme estimated in supernatants from 4-week mice and less than 15% in those at 5 weeks (Fig. 2) . Thus neither the loss of decarboxylase activity which was observed up to 5 weeks after HCB nor the continued inhibition at 14 weeks could be accounted for solely by endogenous uroporphyrins interfering in the assay procedure.
Isomeric composition of uroporphyrin
In the experiment shown in Fig. 1(b) the ratio of uroporphyrin I to III was determined from the time of the first accumulation of porphyrins at 4 weeks to 14 weeks. Between 4 and 8 weeks the proportions of these isomers were reversed so that, as the porphyria developed, uroporphyrin I became the major isomer present (Fig. 3) .
Induction of ethoxyphenoxazone de-ethylase
The induction of porphyria by polyhalogenated aromatic chemicals has been associated, at least partly, with the induction of the cytochrome P-450 isoenzymes induced by polycyclic aromatic hydrocarbons such as 3-methylcholanthrene and ,J-naphthoflavone (Jones & Sweeney, 1980; Sinclair et al., 1984; Smith et al., 1986a) . A good enzymic marker for this induction is microsomal ethoxyphenoxazone de-ethylase (Burke & Mayer, 1983) .
Induced levels of cytochrome P-450 and ethoxyphenoxazone de-ethylase activity by HCB were found to be greatest at 5 days (Figs. 4a and 4b ) at approximately the same time as the level of HCB (Fig. 1 c) . However, even after 8 weeks both cytochrome P-450 and de-ethylase were still significantly elevated over pre-dose values. In contrast, the induction of cytosolic diaphorase activity, which is partly associated with cytochrome P-450 induction of this type (Kumaki et al., 1977) , returned to control values by 5 weeks (Fig. 4c) . cytochrome P450, and(c) cytosolic NAD(P)H diapborase activity in the livers of C57BL/10 mice Enzymes were assayed as described in the Experimental section. Results are means + S.E.M. for four mice per group.
Modification in vivo of the inhibition of uroporphyrinogen decarboxylase
Multiple treatments of mice with inducers of cytochrome P-450 and other chemicals were investigated to determine their influence on the inhibition of uroporphyrinogen decarboxylase caused by HCB (Table 1) . ,-Naphthoflavone significantly enhanced the inhibition of the enzyme and the accumulation of porphyrins. By itself ,B-naphthoflavone had no detectable effqct on decarboxylase activity, although a slight rise in porphyrins of the uroporphyrin type was observed by fluorescence spectroscopy (Granick et al., 1975) . The influences of phenobarbital and isosafrole (results not shown) were less certain. Piperonyl butoxide, an inhibitor of cytochrome P-450-mediated enzyme activities, partially protected against decarboxylase inhibition whereas an antioxidant, butylated hydroxyanisole, was ineffective.
Experiment in vivo with 114CJHCB
To determine whether inhibition of the decarboxylase was caused by binding of a carbon-containing metabolite of HCB, eight C57BL/10 mice preloaded with iron received 100 mg/kg of the chemical. After 3 weeks each mouse was given 1 ,uCi of [14C]HCB and left for 5 days. A combined homogenate of the livers was mixed with an equal volume of control homogenate, centrifuged at 40000 g, precipitated with (NH4)2SO4 and chromatographed on DEAE-Sephacel and phenyl-Sepharose until the uroporphyrinogen decarboxylase had been purified 120-fold (see the Experimental section). Discrete peaks of radioactivity were observed during chromatography but the specific radioactivity of the decarboxylase fraction fell from 4073 d.p.m./unit of enzyme activity in the mixed homogenate to < 0.2 d.p.m./unit at the final step. This final value represented a level of measured radioactivity (< 1 d.p.m.) which was not significantly different from background.
Incubations of HCB-induced microsomes with control cytosol
Microsomes from control and HCB-induced C57BL/10 mice with iron overload were incubated with control 100000 g cytosol and HCB (30 /uM) for 20 min. Pentachlorophenol did not accumulate with control microsomes as opposed to 27 + 5 pmol/mg ofmicrosomal protein (n = 4) with HCB-induced microsomes. Although subsequent assay of uroporphyrinogen decarboxylase suggested that there was a slight loss of enzyme activity in the HCB-induced group (control 38.4 +1. 1, HCB 36.0 + 0.5 pmol/min per mg of protein), this was not statistically significant. Table 2 . Comparison between lipid peroxidation and metabolism of HCB in bepatic microsomes of C57BL/10 and DBA/2 mice Mice were pretreated with iron (500 mg/kg 3 days before any other treatment), HCB (100 mg/kg 5 days before preparation of microsomes) or /i-naphthoflavone (100 mg/kg 2 days before preparation of microsomes) as described in the Experimental section. Cytochrome P450 levels were determined at the time of microsomal preparation. Incubations were based on those described previously (Stewart & Smith, 1986 ) and consisted of 3.4 ml of 0.1 M-Na2HPO4/NaH2PO4 buffer (pH 7.4), approx. 13 mg of microsomal protein and an NADPH regenerating system. HCB (100 nmol) was added in acetone (30,ul) . After 30 min at 37°C lipid peroxidation as malondialdehyde formation and HCB metabolism as pentachlorophenol accumulation were estimated in different incubations but the same microsomal fraction. n.d., not detected at 0.05 pmol/min per mg of microsomal protein. Zero time malondialdehyde values were subtracted from peroxidation results. C57BL/10 and DBA/2 microsomes incubated in the absence of HCB gave the following malondialdehyde values: control, C57BL/ 10 114 + 5, DBA/2 8 + 3t; iron, C57BL/10 211 + 11, DBA/2 21 +4t pmol/min per mg of protein. Results are means+S.E.M. for four or five mice per group. Significantly different from controls: *P < 0.001, **P < 0.005, ***P < 0.05; significantly different from C57BL/10 group: tP<0.001. Comparison between HCB metabolism and lipid peroxidation in C57BL/10 and DBA/2 microsomes The metabolism of HCB to pentachlorophenol was not detected in control or iron overload microsomes from either C57BL/10 or DBA/2 mice. Pretreatment with HCB induced pentachlorophenol formation in both strains, but this was not significantly stimulated by the combination of iron and HCB to any greater extent than by HCB alone. There was only a small difference between the strains (Table 2 ). In contrast, the amount of malondialdehyde formed was 8-fold more by microsomes from control C57BL/10 mice than by those from DBA/2 animals. Iron treatment yielded greater amounts of malondialdehyde with both strains but the strain difference was still maintained (Table 2) Previously it had been assumed that the induction of hepatic porphyria in rodents by HCB required continual exposure for a prolonged period (Elder, 1978) . In contrast, the findings here show that a single ingestion of HCB will cause a progressive inhibition of uroporphyrinogen decarboxylase in siderotic C57BL/10 mice probably beginning within a few days and lasting many weeks. Although a time lag of some weeks before the enzyme in rodents is inhibited by HCB has been reported (Elder, 1978; Smith et al., 1979 Smith et al., , 1986a these results and other published work (Smith et al., 1981; Smith & Francis, 1983; Wainstok de Calmanovici et al., 1984) demonstrate that the lag phase can be much shorter. Prolonged inhibition of the enzyme does not appear to be dirfctly correlated with levels of HCB in the liver or with inductions of total cytochrome P-450 and microsomal ethoxyphenoxazone de-ethylase activity. If these parameters are involved in the inhibition they must still be sufficient after 14 weeks to maintain the depression of uroporphyrinogen decarboxylase activity (Koss et al., 1983; Khanna & Smith, 1985; . The accumulation of liver porphyrins is probably potentiated by induction of aminolaevulinate synthase (EC 2.3.1.37) (Wainstok de Calmanovici et al., 1984) partly explaining the disparities between decarboxylase inhibition and porphyrin levels that were sometimes observed. This underlines the importance of measuring decarboxylase activity in studies of this kind.
A specific type of liver damage is seen in sporadic PCT patients . The elevation of plasma alanine aminotransferase activity at approximately the same time as hepatic porphyrin levels suggests that in the mice the latter may be one cause of liver damage. Whether similar effects occur in human PCT is unknown.
Changes in the proportions of uroporphyrin isomers during the development of porphyria is again of considerable interest with respect to human PCT in which uroporphyrin I predominates over the III isomer (Dowdle et al., 1970) . One explanation might be that uroporphyrinogen III synthase (EC 4.2.1.75) is inhibited either by iron (Kushner et al., 1972) or by the accumulating uroporphyrinogens and uroporphyrins (Levin, 1971) . The unstable hydroxymethylbilane substrate might then spontaneously cyclize to uroporphyrinogen I rather than be transformed to uroporphyrinogen III. Alternatively, there may be an increased tendency in HCB-treated tissue for hydroxymethylbilane to be cyclized to uroporphyrinogen I and porphyrinogens oxidized to porphyrins. These possibilities should also be considered when equating uroporphyrin accumulation with uroporphyrinogen decarboxylase inhibition in experimental systems. Mechanism of the inhibition of uroporphyrinogen decarboxylase There is considerable evidence to suggest that two of the major factors associated with the inhibition of uroporphyrinogen decarboxylase by HCB and other polyhalogenated chemicals are: (a) the induction of cytochrome P1-450 controlled by the Ah locus in mice (Jones & Sweeney, 1980; Smith et al., 1986a) or related isoenzymes in other experimental models of PCT (Carpenter et al., 1984; Sinclair et al., 1984) ; (b) the presence of some unknown non-haem iron species (Taljaard et al., 1972; Louw et al., 1977; Smith et al., 1979; Jones et al., 1981; Smith & Francis, 1983; Ferioli et al., 1984; Greig et al., 1984) . Whether mice become porphyric would seem to depend partly on a balance between liver iron content and the potency of a particular chemical to induce Ah-type microsomal mono-oxygenase activities in both Ah-responsive and Ah-nonresponsive strains (Smith & Francis, 1983; Greig et al., 1984; Smith et al., 1986a) . In agreement with this, the nonchlorinated Ah-type inducers 3-methylcholanthrene and /1-naphthoflavone will potentiate the effects of HCB and related chemicals much more than phenobarbital (Table 1; Carpenter et al., 1984; Sinclair et al., 1984) and partial protection is afforded by an inhibitor of cytochrome P-450, piperonyl butoxide (Table 1; Sinclair et al., 1984) . Induction of a cytochrome P1-450 isoenzyme alone may not be sufficient for a porphyrogenic response since we were unable to detect any loss of decarboxylase activity after treatment with ,-naphthoflavone, although, interestingly, some abnormalities in porphyrin accumulation were observed.
How do these factors cause an inhibition of hepatic uroporphyrinogen decarboxylase? HCB may be metabolized by cytochrome P1450 in a process, stimulated by iron, to a product which inhibits or covalently binds with the enzyme. However, incubation of microsomes from the susceptible C57BL/10 strain and the non-susceptible DBA/2 strain (Smith & Francis, 1983) with HCB has not shown convincing evidence for either differential metabolism or stimulation by iron overload (Table 1) . Similar results have been obtained in vivo (Khanna & Smith, 1985) . In addition, no radiolabelling ofuroporphyrinogen decarboxylase was detected in experiments with [14C]HCB. These findings agree with studies on rats in which there was no correlation between metabolism of HCB and the marked sex difference in susceptibility to porphyria (Rizzardini & Smith, 1982; Stewart & Smith, 1986) .
A free radical-mediated mechanism for the porphyrogenicity of TCDD was proposed by Jones et at. (1981) because of the protection afforded by iron depletion and by dietary butylated hydroxyanisole (Sweeney, 1982) . We have been unable to find any protective effect of this antioxidant (similar results have been reported for rats; Debets et al., 1981) , but the great enhancement by iron overload of both HCB and TCDD porphyrogenicity in mice (Smith & Francis, 1983; Greig et al., 1984) would be consistent with a related mechanism perhaps involving interaction between microsomal electron transport and ferritin (De Matteis & Stonard, 1977; Rowley & Sweeney, 1984) . Siderotic mice fed HCB produce more lipid peroxidation products than do controls (Smith et al., 1986b) but the finding of a marked difference between hepatic microsomes from C57BL/10 and DBA/2 mice in the production of malondialdehyde, the oxidation of NADPH and 02 consumption, may be of greater relevance despite the lack of induction by HCB. Cheeseman et al. (1985) have shown a similar difference between control microsomes from C57BL/6 and DBA/2 mice with the ADP/Fe2+ system, but not with other methods of stimulating microsomal lipid peroxidation. This difference between the mouse strains remains unexplained. A free radical process with production of an active oxygen species might, in the presence of porphyrin, lead to inactivation of uroporphyrinogen decarboxylase at the active site perhaps involving a thiol group (Elder et al., 1985) . Immunoreactive decarboxylase is still present in HCB-and TCDD-induced porphyria (Elder & Sheppard, 1982) . Alternatively, a high-affinity inhibitor (Cantoni et al., 1984) may be produced which is not a metabolite of HCB.
The relevance of the mechanism of the induction of porphyria in experimental animals by polyhalogenated aromatic chemicals to our understanding of the pathogenesis of human sporadic PCT is still not unequivocably established. However, a mechanism which does not involve inhibition of the enzyme by a metabolite of the chemical would be attractive in linking these two manifestations of depressed hepatic uroporphyrinogen decarboxylase activity.
